Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The long-term effects of prenatal development on growth and metabolism.

Godfrey KM, Inskip HM, Hanson MA.

Semin Reprod Med. 2011 May;29(3):257-65. doi: 10.1055/s-0031-1275518. Epub 2011 Jul 18. Review.

2.

Cardiovascular and metabolic influences of fetal smoke exposure.

Bakker H, Jaddoe VW.

Eur J Epidemiol. 2011 Oct;26(10):763-70. doi: 10.1007/s10654-011-9621-2. Epub 2011 Oct 13. Review.

3.

Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.

Szostak-Węgierek D, Szamotulska K.

Med Wieku Rozwoj. 2011 Jul-Sep;15(3):203-15. Review.

4.
5.

Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome.

Fernandez-Twinn DS, Ozanne SE.

Physiol Behav. 2006 Jun 30;88(3):234-43. Epub 2006 Jun 19. Review.

PMID:
16782139
6.

The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.

Thorn SR, Rozance PJ, Brown LD, Hay WW Jr.

Semin Reprod Med. 2011 May;29(3):225-36. doi: 10.1055/s-0031-1275516. Epub 2011 Jun 27. Review.

7.

Developmental mismatch: consequences for later cardiorespiratory health.

Pike KC, Hanson MA, Godfrey KM.

BJOG. 2008 Jan;115(2):149-57. Review.

8.

[Foetal programming of nutrition-related chronic diseases].

Delisle H.

Sante. 2002 Jan-Mar;12(1):56-63. Review. French.

9.

Developmental plasticity and human disease: research directions.

Gluckman PD, Hanson MA.

J Intern Med. 2007 May;261(5):461-71. Review.

10.

[The transgenerational mechanisms in developmental programming of metabolic diseases].

Zambrano E.

Rev Invest Clin. 2009 Jan-Feb;61(1):41-52. Review. Spanish.

PMID:
19507474
11.

Fetal programming of coronary heart disease.

Barker DJ.

Trends Endocrinol Metab. 2002 Nov;13(9):364-8. Review.

PMID:
12367816
12.
13.

Metabolic disease: evolutionary, developmental and transgenerational influences.

Gluckman PD, Hanson MA.

Nestle Nutr Workshop Ser Pediatr Program. 2005;55:17-27. Review. No abstract available.

PMID:
16632926
14.

Short-term and long-term sequelae in intrauterine growth retardation (IUGR).

Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M.

J Matern Fetal Neonatal Med. 2013 Feb;26(3):222-5. doi: 10.3109/14767058.2012.715006. Epub 2012 Oct 3.

PMID:
23030765
15.

Embryonic and fetal programming of physiological disorders in adulthood.

Lau C, Rogers JM.

Birth Defects Res C Embryo Today. 2004 Dec;72(4):300-12. Review.

PMID:
15662709
16.

Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring.

Metzger BE.

Clin Obstet Gynecol. 2007 Dec;50(4):972-9. Review.

PMID:
17982340
17.

Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease.

Rogers LK, Velten M.

Life Sci. 2011 Sep 26;89(13-14):417-21. doi: 10.1016/j.lfs.2011.07.017. Epub 2011 Jul 28. Review.

PMID:
21821056
18.

Developmental origins of metabolic disease: life course and intergenerational perspectives.

Godfrey KM, Gluckman PD, Hanson MA.

Trends Endocrinol Metab. 2010 Apr;21(4):199-205. doi: 10.1016/j.tem.2009.12.008. Epub 2010 Jan 14. Review.

PMID:
20080045
19.

Developmental plasticity and epigenetic mechanisms underpinning metabolic and cardiovascular diseases.

Low FM, Gluckman PD, Hanson MA.

Epigenomics. 2011 Jun;3(3):279-94. doi: 10.2217/epi.11.17. Review.

PMID:
22122338
20.

Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders.

Mierzynski R, Dluski D, Darmochwal-Kolarz D, Poniedziałek-Czajkowska E, Leszczynska-Gorzelak B, Kimber-Trojnar Z, Agnieszka-Wankowicz, Oleszczuk J.

Curr Pharm Biotechnol. 2016;17(7):587-96. Review.

PMID:
26927210

Supplemental Content

Support Center